financetom
AKYA
financetom
/
Healthcare
/
AKYA
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Akoya Biosciences, Inc.AKYA
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa.

The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow.

It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI.

The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Latest News >
Sam Altman’s Worldcoin to Launch L2 Blockchain Prioritizing Human Transactions
Sam Altman’s Worldcoin to Launch L2 Blockchain Prioritizing Human Transactions
Apr 18, 2024
Worldcoin, the project co-founded by Open AI CEO Sam Altman, which uses iris-scanning technology to verify a users “humanness,” is planning to launch an Ethereum layer-2 blockchain prioritizing verified humans over bots. Worldcoin currently has more than 10 million users, with 50% of them having verified their human identities using the projects Orb. An Anti-Bot Blockchain Network In a blog...
Market Chatter: ConocoPhillips Could Be Roped in to Bid for Venezuela-tied Citgo
Market Chatter: ConocoPhillips Could Be Roped in to Bid for Venezuela-tied Citgo
Apr 18, 2024
02:00 PM EDT, 04/18/2024 (MT Newswires) -- ConocoPhillips ( COP ) could be in the race to bid for shares in PDV Holding which owns Houston-based oil refiner Citgo Petroleum, Reuters reported Thursday, citing people close to the matter. A group of investors and creditors, represented by Centerview Partners is preparing to bid for the holding company. A US court...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Marsh & Mclennan Companies, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Marsh & Mclennan Companies, Inc.
Apr 18, 2024
02:05 PM EDT, 04/18/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price of $215, valuing MMC shares at 22.8x our '25 adjusted EPS estimate of $9.45 and at 24.7x our '24 EPS estimate of $8.70 (raised...
German Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline
German Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline
Apr 18, 2024
Thursday, Germany’s competition authority, Bundeskartellamt, cleared the planned acquisition of Cardior Pharmaceuticals GmbH by Danish pharma giant Novo Nordisk A/S ( NVO ) . Cardior is a biotech company focusing on heart diseases, in the case at hand cardiac insufficiency or heart failure.  The company has not yet offered any approved substances. Cardior’s main development product is an active substance against cardiac insufficiency caused by heart...
Copyright 2023-2026 - www.financetom.com All Rights Reserved